CyberSecBulletin
CVE-2023-40150NVD status: Modified

MedDream PACS: Exposed Dangerous Method or Function

CVE-2023-40150 is a critical-severity exposed dangerous method or function vulnerability in MedDream PACS from Softneta, with a CVSS 3.1 base score of 9.8 out of 10. It can be exploited remotely over the network by an unauthenticated attacker, without any action from a user. Affected MedDream PACS versions: v7.2.8.810 and earlier. The record does not name a fixed version, so check the vendor advisory. There is no confirmed exploitation so far. EPSS estimates a 1.26% chance of exploitation within 30 days, higher than 70% of scored CVEs.

Patch this week

Critical severity: a successful attack would have severe impact.

What to do

  1. Check which version of MedDream PACS you run against the affected versions below, and install the vendor's latest release.
  2. Until you can update, restrict network access to the affected service so it is not reachable from untrusted networks.

Affected products and versions

VendorProductAffected versionsFixed in
SoftnetaMedDream PACSv7.2.8.810 and earlierNot stated

Version data comes from the organisation that assigned the CVE. Confirm against the vendor advisory before deciding you are unaffected.

How the severity score breaks down

Attack vector
NetworkCan be exploited remotely over a network, including the internet.
Attack complexity
LowNo special conditions are needed; the attack works reliably.
Privileges required
NoneNo account or login is needed.
User interaction
NoneNo action by a victim is required.
Scope
UnchangedImpact stays within the vulnerable component.
Confidentiality
HighAll data handled by the component can be read.
Integrity
HighData or code can be modified at will.
Availability
HighThe component can be taken down completely.

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H. Scored by NVD.

Scoring systemScoreSeverityScored by
CVSS 3.19.8CriticalCNA (hq.dhs.gov)
CVSS 3.19.8CriticalNVD

Official description

Softneta MedDream PACS does not perform an authentication check and performs some dangerous functionality, which could result in unauthenticated remote code execution.0

Source: the CVE record as published by its numbering authority, via NVD and CVE.org.

The underlying weakness: Exposed Dangerous Method or Function

The product provides an Applications Programming Interface (API) or similar interface for interaction with external actors, but the interface includes a dangerous method or function that is not properly restricted.

How developers prevent this class of flaw

  • If you must expose a method, make sure to perform input validation on all arguments, limit access to authorized parties, and protect against all possible vulnerabilities.
  • Identify all exposed functionality. Explicitly list all functionality that must be exposed to some user or set of users. Identify which functionality may be: accessible to all users restricted to a small set of privileged users prevented from being directly accessible at all Ensure that the implemented code follows these expectations. This includes setting the appropriate access modifiers where applicable (public, private, protected, etc.) or not marking ActiveX controls safe-for-scripting.

More Exposed Dangerous Method or Function vulnerabilities (CWE-749)

Timeline

  1. CVE record published.
  2. CISA published its SSVC assessment (exploitation: none, automatable: yes, technical impact: total).
  3. Record last changed materially (score, affected products, status or references).

Other vulnerabilities in MedDream PACS

All MedDream PACS vulnerabilities

Recent Exposed Dangerous Method or Function vulnerabilities

Spotted an error? Tell us.